Community Healthcare Trust Incorporated
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CHCT research report →
Range $17 – $17
Price Chart
About the company
Community Healthcare Trust Incorporated is a real estate investment trust. It focuses on owning income-producing real estate properties associated primarily with the delivery of outpatient healthcare services in our target sub-markets throughout the United States. As of December 31, 2025, the Company had investments of approximately 1.
- CEO
- David H. Dupuy
- IPO
- 2015
- Employees
- 35
- HQ
- Franklin, TN, US
Get TickerSpark's AI analysis on CHCT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $409.25M
- P/E
- 19.55
- Fwd P/E
- 34.73
- PEG
- 0.01
- P/S
- 3.26
- P/B
- 0.94
- EV/EBITDA
- 9.86
- Div Yield
- 11.32%
- Gross Margin
- 63.65%
- Op Margin
- 31.77%
- Net Margin
- 17.76%
- ROE
- 5.34%
- ROIC
- 4.00%
Latest fiscal year · YoY change
- Revenue
- $121.19M+4.7%
- Gross Profit
- $10.49M-88.7%
- Op Income
- $20.27M
- Net Income
- $5.10M+260.4%
- EPS
- $0.08+133.7%
- OCF Growth
- -4.2%
- FCF Growth
- +4.9%
- 52W High
- $19.17
- 52W Low
- $12.58
- 50D MA
- $13.92
- 200D MA
- $16.20
- Beta
- 0.63
- RSI (14)
- 53
- Avg Volume
- 368.66K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Community Healthcare Trust delivered higher revenue, FFO, and AFFO in Q3 while improving occupancy, reducing G&A, and advancing capital recycling and redevelopment.· November 4, 2026
- Occupancy rose to 90.1% from 89.8% in Q2 as leasing activity remained strong.
- Revenue increased to $32.4 million, up 4.4% year over year, and FFO rose to $15 million, or $0.54 per diluted share.
- AFFO reached $16 million, or $0.58 per diluted share, up 6.1% year over year.
- G&A fell to $4.2 million, down about $700,000 sequentially and about $470,000 year over year.
- Asset sales produced $32.8 million of net proceeds, and the company still has more than $30 million of properties marketed for disposition.
Total revenue was $32.4 million in Q3 2026, up 4.4% from $31.1 million in Q3 2025 and up 3.9% from $31.2 million in Q2 2026. Property operating expenses were about $6 million, up only about $100,000 sequentially and less than $50,000, or less than 1%, year over year. General and administrative expense was $4.2 million, down about $700,000 sequentially and about $470,000 year over year. Interest expense was $7.5 million, up less than $100,000 sequentially. FFO was $15 million, or $0.54 per diluted share, versus $13.5 million, or $0.50, a year ago; AFFO was $16 million, or $0.58 per diluted share, versus $15.1 million, or $0.56 a year ago. Occupancy improved to 90.1% from 89.8% in the prior quarter, and leverage declined to 5.8x. The dividend was held at $0.33 per common share, or $1.32 annualized. Management also said it signed agreements to acquire 4 properties for an aggregate expected purchase price of $99 million, with expected returns of 9.1% to 9.75%. For the outlook, management said it expects G&A to remain lower year over year for the next few quarters, sees 9% to 10% acquisition yields as achievable, and expects transaction activity to accelerate through 2027 as disposition proceeds are realized.
Dave Dupuy framed the quarter around four strategic priorities: improving occupancy, reinvesting through redevelopment and speculative suites, recycling capital, and accelerating acquisitions. He said leasing activity was robust, the redevelopment pipeline remains on schedule, and the company is using dispositions to fund higher-yielding acquisitions while keeping leverage modest. His tone was constructive and confident, but he also acknowledged that some vacant buildings are difficult to lease and may need to be sold if they are not good long-term fits.
Bill Monroe emphasized that the quarter was strong across the board, with revenue up 4.4% year over year to $32.4 million and FFO and AFFO both improving meaningfully. He pointed to lower G&A of $4.2 million as a major driver of profit growth, noting that the decline reflects compensation and stock-based compensation actions and that G&A should stay lower year over year for the next few quarters. He also said interest expense rose slightly to $7.5 million, leverage fell to 5.8x, and the company had no incremental revolver borrowings during the quarter.
Analysts focused on vacancy strategy, the market for 1031 buyers, the nonrecurring pieces of the quarter, and the long-delayed transaction involving the geriatric behavioral hospital operator. Management said the vacancy approach will be a mix of leasing and selective sales of smaller, less strategic buildings, and that the disposition market has been very robust for the targeted assets they are selling. On the delayed transaction, Dupuy said exclusivity has expired, the business performance has improved, and the company is exploring alternatives while still hoping the deal closes. Monroe said there was nothing material in the quarter’s results that he viewed as nonrecurring, aside from the normal timing around capital recycling and the associated leakage until replacement acquisitions close.
The call showed improving occupancy, strong leasing momentum, and clear evidence that cost discipline is flowing through to earnings. Management also sounded increasingly confident that its disposition program can fund a pipeline of higher-yielding acquisitions, with 9% to 10% returns described as achievable and more activity expected in coming quarters.
The company still has a handful of vacant buildings, including some that management described as difficult and expensive to lease, which may need to be sold instead. The large behavioral-hospital transaction remains delayed, due diligence has taken longer than expected, and management is frustrated enough to seek alternatives if the current deal does not close.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 93.4%
- Shares Outstanding
- 28.74M
- Float Shares
- 26.84M
of shares held by institutions
175 13F filers
Buy/sell ratio 8.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 3.01M | ▲ 370.07K |
| Vanguard Group Inc | 2.80M | ▼ 2.67K |
| Mirae Asset Global Etfs Holdings Ltd. | 2.06M | ▲ 71.96K |
| Vanguard Portfolio Management LLC | 1.45M | ▼ 4.24K |
| Systematic Financial Management LP | 1.18M | ▲ 58.52K |
| Vanguard Capital Management LLC | 1.17M | ▼ 14.03K |
| Invesco Ltd. | 1.07M | ▲ 87.86K |
| Nuveen, LLC | 937.28K | ▼ 6.11K |
| State Street Corp | 763.60K | ▼ 63.84K |
| Geode Capital Management, LLC | 709.35K | ▼ 104.57K |
| Kennedy Capital Management LLC | 684.02K | ▼ 188.36K |
| Two Sigma Investments, LP | 577.35K | ▲ 22.82K |
Held by 174 ETFs
Biggest fund positions in CHCT by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 18, 26 | Stach Leigh Ann | other | 14,810 |
| Aug 14, 26 | Stach Leigh Ann | other | 4,983 |
| Aug 18, 26 | Monroe William G. IV | other | 27,573 |
| Aug 18, 26 | Dupuy David H. | other | 26,853 |
| Aug 14, 26 | Dupuy David H. | buy | 10,000 |
| Aug 11, 26 | Hensley Robert Z | buy | 8,000 |
| Jul 30, 26 | Stach Leigh Ann | other | 8,589 |
| Jul 30, 26 | Monroe William G. IV | other | 10,163 |
| Jul 30, 26 | Dupuy David H. | other | 15,573 |
| Jun 30, 26 | Monroe William G. IV | other | 1,630 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our CHCT coverage
Recent articles, reports, and earnings notes.
Want a deeper read on CHCT?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Is Community Healthcare Trust (CHCT) a Great Value Stock Right Now?
zacks.com · Nov 11
Blue Wave Fuels REIT Rally
seekingalpha.com · Nov 8
What Community Healthcare Trust (CHCT) Said on Its Q3 Earnings Call
marketbeat.com · Nov 5
Community Healthcare Trust: The 9.2% Yield Is Looking Safer
seekingalpha.com · Nov 4
Community Healthcare Trust Incorporated (CHCT) Q3 2026 Earnings Call Transcript
seekingalpha.com · Nov 4
Community Healthcare Trust (CHCT) Q3 FFO and Revenues Beat Estimates
zacks.com · Nov 3
Community Healthcare Trust Announces Results for the Three Months Ended September 30, 2026
prnewswire.com · Nov 3
Community Healthcare Trust: Cheap After Dividend Cut, But This 10% REIT Is A Hold
seekingalpha.com · Oct 21
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
